🔆 Overview

✅ Fully funded summer research internship in Japan
✅ Hosted by University of Tokyo (UTokyo)
✅ Open for undergraduate students (mainly from Asia region)
✅ Duration: 8-weeks of hands-on research in biomedical & life sciences
✅ Prestigious Amgen Scholars program active globally (US since 2006, Europe since 2008, Japan since 2015)

🔆 Host Details
✅ Host Country: Japan
✅ Host University: University of Tokyo
✅ Host Organization: Amgen Foundation
✅ No. of Scholarships: 10

🔆 Program Highlights
✅ Work with top professors and researchers at UTokyo
✅ Intensive biomedical & life science labs training
✅ Cultural immersion and networking with global peers
✅ Academic sessions & visits to top research institutes

🔆 Benefits
✅ Free accommodation
✅ Stipend of 280,000 JPY
✅ Economy-class airfare to Tokyo (or domestic travel covered)
✅ Access to UTokyo library & health care services
✅ Info sessions on UTokyo graduate programs
✅ Japanese cultural events & short trips
✅ Seminars, research meetings & special sessions

🔆 Eligibility Criteria
✅ Must be an undergraduate student (Bachelor’s degree awarding institution, mainly Asia region)
✅ Completed at least 1 year of study before the program starts
✅ Not graduating before the program begins
✅ Must have at least one semester remaining after program ends
✅ Strong academic record & interest in research/PhD path
✅ English proficiency required (minimum):
✅ TOEFL iBT: 72
✅ IELTS: 5.5
✅ Cambridge English FCE
✅ TOEIC: 1095 (or TOEIC L&R: 785 and TOEIC S&W: 310)

🔆 Required Documents
✅ Passport-style photo
✅ Valid personal ID
✅ Academic transcript
✅ English proficiency proof
✅ Updated CV
✅ Two recommendation letters (one must be faculty)

🔆 How to Apply
✅ Register on TAO portal using full legal name
✅ Select “UTokyo Amgen Scholars Program” and start application
✅ Upload all required documents
✅ Request two recommendation letters via TAO
✅ Review & complete entire application (no edits after submission)
✅ Selection review: February to mid-March
✅ Results via TAO portal & email

🔆 Deadline
✅ February 1, 2026